Agios Pharmaceuticals, Inc. (AGIO)
35.20
+1.01
(+2.95%)
USD |
NASDAQ |
Apr 02, 16:00
35.21
+0.01
(+0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Market Cap : 2.124B for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 819.44B |
| Biogen, Inc. | 25.11B |
| Catalyst Pharmaceuticals, Inc. | 2.997B |
| Apellis Pharmaceuticals, Inc. | 5.168B |
| Alnylam Pharmaceuticals, Inc. | 40.99B |
Market Cap Related Metrics
| PS Ratio | 37.77 |
| Price to Book Value | 1.729 |
| Price | 35.20 |
| Earnings Yield | -20.22% |